GARDP https://gardp.org Global Antibiotic Research and Development Partnership Tue, 07 Apr 2026 15:02:03 +0000 en-US hourly 1 https://gardp.org/wp-content/uploads/2022/02/cropped-Group-6-32x32.png GARDP https://gardp.org 32 32 The European Commission invests in CARB-X and GARDP to ramp up global response to antimicrobial resistance https://gardp.org/the-european-commission-invests-in-carb-x-and-gardp-to-ramp-up-global-response-to-antimicrobial-resistance/ Tue, 07 Apr 2026 14:58:14 +0000 https://gardp.org/?p=23308 ... The European Commission invests in CARB-X and GARDP to ramp up global response to antimicrobial resistance

Source

]]> Antabio and GARDP join forces to identify potential next-generation antibiotics https://gardp.org/antabio-and-gardp-join-forces-to-identify-potential-next-generation-antibiotics/ Mon, 23 Mar 2026 09:35:48 +0000 https://gardp.org/?p=23280 ... Antabio and GARDP join forces to identify potential next-generation antibiotics

Source

]]> GARDP revives clinical research into apramycin as potential treatment for life-threatening ‘superbugs’ https://gardp.org/gardp-revives-clinical-research-into-apramycin-as-potential-treatment-for-life-threatening-superbugs/ Thu, 05 Mar 2026 07:59:12 +0000 https://gardp.org/?p=23253 ... GARDP revives clinical research into apramycin as potential treatment for life-threatening ‘superbugs’

Source

]]> We are at a dangerous tipping point with drug-resistant infections – global insecurity makes it worse https://gardp.org/we-are-at-a-dangerous-tipping-point-with-drug-resistant-infections-global-insecurity-makes-it-worse/ Fri, 13 Feb 2026 14:28:05 +0000 https://gardp.org/?p=23235 ... We are at a dangerous tipping point with drug-resistant infections – global insecurity makes it worse

Source

]]> GARDP Executive Director named among TIME’s 100 most influential people in health https://gardp.org/dr-manica-balasegaram-named-to-time-100-health-2026/ Thu, 12 Feb 2026 07:54:45 +0000 https://gardp.org/?p=23223 ... GARDP Executive Director named among TIME’s 100 most influential people in health

Source

]]> Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance https://gardp.org/statement-on-brazils-draft-national-action-plan-for-antimicrobial-resistance/ Tue, 10 Feb 2026 07:34:35 +0000 https://gardp.org/?p=23215 ... Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance

Source

]]> GARDP and Debiopharm partner to advance development of novel gonorrhoea drug https://gardp.org/gardp-and-debiopharm-partner-to-advance-development-of-novel-gonorrhoea-drug/ Tue, 13 Jan 2026 13:00:29 +0000 https://gardp.org/?p=23159 ... GARDP and Debiopharm partner to advance development of novel gonorrhoea drug

Source

]]> GARDP, Debiopharm to collaborate on new gonorrhea antibiotic https://gardp.org/gardp-debiopharm-to-collaborate-on-new-gonorrhea-antibiotic/ Tue, 13 Jan 2026 09:08:16 +0000 https://gardp.org/?p=23174 ... GARDP, Debiopharm to collaborate on new gonorrhea antibiotic

Source

]]> US FDA approval of Nuzolvence® (zoliflodacin), a first-in-class antibiotic for gonorrhoea https://gardp.org/us-fda-approval-of-nuzolvence/ Tue, 16 Dec 2025 09:37:45 +0000 https://gardp.org/?p=23121 ... US FDA approval of Nuzolvence® (zoliflodacin), a first-in-class antibiotic for gonorrhoea

Source

]]> NUZOLVENCE® (Zoliflodacin), First-in-Class Oral Antibiotic for Gonorrhoea, Receives U.S. FDA Approval https://gardp.org/nuzolvence-zoliflodacin-first-in-class-oral-antibiotic-for-gonorrhoea-receives-u-s-fda-approval/ Fri, 12 Dec 2025 19:35:57 +0000 https://gardp.org/?p=23095 ... NUZOLVENCE® (Zoliflodacin), First-in-Class Oral Antibiotic for Gonorrhoea, Receives U.S. FDA Approval

Source

]]>